Table 1.
Table 1 | Kd (nM) |
---|---|
ABL | 9.9 ± 1.6 |
SRC | 13 ± 2 |
HCK | 8.7 ± 0.6 |
LCK | 20 ± 2 |
p38 | 35 ± 11 |
CSK | 17 ± 3 |
EPHA3 | 27 ± 5 |
CLK1 | >1000 |
PAK4 | >1000 |
PAK5 | >1000 |
MAP3K5 | >1000 |
Table 1 | Kd (nM) |
---|---|
ABL | 9.9 ± 1.6 |
SRC | 13 ± 2 |
HCK | 8.7 ± 0.6 |
LCK | 20 ± 2 |
p38 | 35 ± 11 |
CSK | 17 ± 3 |
EPHA3 | 27 ± 5 |
CLK1 | >1000 |
PAK4 | >1000 |
PAK5 | >1000 |
MAP3K5 | >1000 |